Indian pharmaceutical organization Strides Pharma Science Ltd said on Thursday it has acquired administrative endorsement to direct clinical preliminaries of antiviral medication favipiravir, a potential treatment for COVID-19.

The organization has gotten endorsement from the Drug Controller General of India to direct preliminaries of favipiravir in the nation, Strides Founder and Non-Executive Chairman Arun Kumar said on a post-income telephone call.

Portions of the organization rose as much as 5.3% to a fourteen day high in early exchange, and were last up 3.5% at 0408 GMT.